Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma
Titel:
Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma
Auteur:
Viganò, M. Grossi, G. Borsotti, E. Cappelletti, M. Goldaniga, M. Farina, L. Rumi, M. Corradini, P. Baldini, L. Colombo, M. Lampertico, P.